Kitabis Pak is available in cartons containing one reusable PARI LC Plus Nebulizer and 14 Tobramycin Inhalation Solution pouches. Each pouch contains four 300mg/5mL ampules of Tobramycin. Pricing of ...

Please provide your email address to receive an email when new articles are posted on . Tobramycin inhalation solution was effective in lowering bacterial density and positively influenced quality of ...

COLUMBIA, S.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- The Ritedose Corporation (Ritedose) announced that the U.S. Food and Drug Administration (FDA) approved its manufacturing and distribution of ...

The antibiotic is primarily used for chronic Pseudomonas aeruginosa infections in patients with CF. Tobramycin is an aminoglycoside antibiotic indicated for the treatment of serious bacterial ...

Kitabis Pak (tobramycin inhalation solution) is now on the Preferred Drug List (PDL) for many state programs, expanding its access for patients with cystic fibrosis (CF) using nebulized antibiotic ...

RICHMOND, Va., Dec. 3, 2014 /PRNewswire/ -- On Tuesday, the FDA granted final approval of PulmoFlow, Inc.'s New Drug Application for Kitabis Pak – a co-packaging of generic tobramycin inhalation ...

The US Food and Drug Administration (FDA) approved a tobramycin inhalation powder (TOBI Podhaler, Novartis) for treating patients with cystic fibrosis (CF) whose lungs are infected with the bacterium ...

EMERYVILLE, Calif. & SAN CARLOS, Calif.--(BUSINESS WIRE)--Oct. 5, 2005--Chiron Corporation (Nasdaq:CHIR) and Nektar Therapeutics (Nasdaq:NKTR) today announced the initiation of clinical testing in the ...

The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE) to produce guidance on using colistimethate sodium dry powder for inhalation and tobramycin dry ...